Stock Scorecard
Stock Summary for Longboard Pharmaceuticals Inc (LBPH) - $59.98 as of 3/28/2025 12:40:21 AM EST
Total Score
9 out of 30
Safety Score
27 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for LBPH
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LBPH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LBPH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for LBPH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for LBPH (27 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for LBPH
Financial Details for LBPH
Company Overview |
|
|---|---|
| Ticker | LBPH |
| Company Name | Longboard Pharmaceuticals Inc |
| Country | N/A |
| Description | Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs for neurological diseases. The company is headquartered in San Diego, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 4/30/2025 |
Stock Price History |
|
| Last Day Price | 59.98 |
| Price 4 Years Ago | 4.88 |
| Last Day Price Updated | 3/28/2025 12:40:21 AM EST |
| Last Day Volume | 655,798 |
| Average Daily Volume | 954,566 |
| 52-Week High | 60.03 |
| 52-Week Low | 15.64 |
| Last Price to 52 Week Low | 283.50% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 37.01 |
| Sector PE | 40.10 |
| 5-Year Average PE | -10.83 |
| Free Cash Flow Ratio | 7.17 |
| Industry Free Cash Flow Ratio | 11.91 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 15.97 |
| Total Cash Per Share | 8.37 |
| Book Value Per Share Most Recent Quarter | 7.05 |
| Price to Book Ratio | 8.51 |
| Industry Price to Book Ratio | 8.86 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 0.00 |
| Industry Price to Sales Ratio Twelve Trailing Months | 88.85 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 34,436,200 |
| Market Capitalization | 2,065,483,276 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -23.84% |
| Reported EPS 12 Trailing Months | -2.25 |
| Reported EPS Past Year | -1.61 |
| Reported EPS Prior Year | -2.38 |
| Net Income Twelve Trailing Months | -76,344,000 |
| Net Income Past Year | -54,422,000 |
| Net Income Prior Year | -43,945,000 |
| Quarterly Revenue Growth YOY | 0.00% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 288,400,000 |
| Total Cash Past Year | 48,500,000 |
| Total Cash Prior Year | 67,600,000 |
| Net Cash Position Most Recent Quarter | 288,400,000 |
| Net Cash Position Past Year | 48,500,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 40,923,000 |
| Total Stockholder Equity Prior Year | 61,470,000 |
| Total Stockholder Equity Most Recent Quarter | 275,186,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -65,931,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.91 |
| Free Cash Flow Past Year | 0 |
| Free Cash Flow Prior Year | -38,063,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.76 |
| MACD Signal | 2.39 |
| 20-Day Bollinger Lower Band | 20.65 |
| 20-Day Bollinger Middle Band | 44.94 |
| 20-Day Bollinger Upper Band | 69.24 |
| Beta | 1.09 |
| RSI | 77.51 |
| 50-Day SMA | 13.61 |
| 150-Day SMA | 13.24 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 3/28/2025 12:40:22 AM EST |